Share this

Selected Safety Information

References:

  1. Gruber MF, Marshall VB. Chapter 80: Regulation and testing of vaccines i n the US. In: Orenstein WA, Offit PA, Edwards KM, Plotkin SA,eds. Plotkin’s Vaccines. 8th ed. Elsevier;2022:1640-1659.e2.
  2. Guidelines on clinical evaluation of vaccines: regulatory expectations. WHO Technical Report Series 1004, Annex 9, 2017. World Health Organization. Accessed January 20, 2025. https://www.who.int/publications/m/item/WHO-TRS-1004-webannex-9.
  3. Recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines, Annex 3, TRS No 977. World Health Organization. October 19, 2013. Accessed January 20, 2025. https://www.who.int/publications/m/item/pneumococcal-conjugate-vaccines-annex3-trs-977.
  4. Gierke R, Wodi AP, Kobayashi M. Chapter 17: Pneumococcal disease. In: Centers for Disease Control and Prevention. Hall E, Wodi AP, Hamborsky J, et al, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 14th ed. Public Health Foundation; 2021:255-274. Accessed January 20, 2025. https://www.cdc.gov/vaccines/pubs/pinkbook/pneumo.html.

AE-PVC-00059 | Exp 20 Jan 2027.